Global Transdermal Patch Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- SKU ID : GIR-GIR1901230373 13813380
- |
- Publishing Date: 29-Mar-2019
- |
- Region: Global
- |
- No. of pages: 116
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.
Scope of the Report:
The technical barriers of transdermal patch are high, and the core technology of transdermal patch concentrates in relative large companies. These companies mainly concentrate in USA, Japan and Germany. Japan account for almost 50% of total transdermal patch in 2015, followed by North America with 29% of production share.
In the past few years, the price of transdermal patch has a little change and we expect the price will slightly lower. However, the improvement of energy, transportation costs, employee wages, and equipment depreciation will play a significant role in promoting the cost of transdermal patch.
As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. With the snatch for market share in emerging regions, the competition in transdermal patch industry will become more intense.
The worldwide market for Transdermal Patch is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Transdermal Patch in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Market Segment by Applications, can be divided into
Used to Stop Smoking Cigarettes
Used to Treat High Blood Pressure
Used to Relieve Severe Pain
Used to Treat an Overactive Bladder
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Patch product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Patch, with price, sales, revenue and global market share of Transdermal Patch in 2017 and 2018.
Chapter 3, the Transdermal Patch competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Patch breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Transdermal Patch market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Transdermal Patch sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
The technical barriers of transdermal patch are high, and the core technology of transdermal patch concentrates in relative large companies. These companies mainly concentrate in USA, Japan and Germany. Japan account for almost 50% of total transdermal patch in 2015, followed by North America with 29% of production share.
In the past few years, the price of transdermal patch has a little change and we expect the price will slightly lower. However, the improvement of energy, transportation costs, employee wages, and equipment depreciation will play a significant role in promoting the cost of transdermal patch.
As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. With the snatch for market share in emerging regions, the competition in transdermal patch industry will become more intense.
The worldwide market for Transdermal Patch is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Transdermal Patch in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Market Segment by Applications, can be divided into
Used to Stop Smoking Cigarettes
Used to Treat High Blood Pressure
Used to Relieve Severe Pain
Used to Treat an Overactive Bladder
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Patch product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Patch, with price, sales, revenue and global market share of Transdermal Patch in 2017 and 2018.
Chapter 3, the Transdermal Patch competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Patch breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Transdermal Patch market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Transdermal Patch sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
